Login / Signup

Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.

Jose Maria Ruiz-MorenoLuís AriasMaximino J AbraldesJavier MonteroPatricia Udaondonull null
Published in: International ophthalmology (2021)
AMD was associated with considerable healthcare costs for regional healthcare systems. Diagnostic examinations, particularly OCT examinations, and anti-VEGF treatment represented the largest cost items.
Keyphrases
  • age related macular degeneration
  • healthcare
  • clinical practice
  • endothelial cells
  • vascular endothelial growth factor
  • diabetic retinopathy
  • health information